Personal Genome Diagnostics
Personal Genome Diagnostics Inc. offers genome analysis of human tumors for research.
Founded
2010Personal Genome Diagnostics Inc. (PGDx) was founded with the mission to empower the fight against cancer through advanced genome analysis. The company focuses on providing comprehensive genomic insights for human tumors, primarily for research purposes. Their flagship product, the PGDx elio tissue complete test, offers rapid and actionable genomic profiling for patients with advanced cancer, analyzing over 500 solid tumor-related genes and identifying various somatic mutations. PGDx aims to revolutionize cancer treatment by enabling precise and personalized therapeutic strategies.
Notable figures affiliated with PGDx include co-founders Dr. Victor Velculescu and Dr. Luis Diaz, both renowned for their contributions to cancer genomics. The company has attracted significant investment from entities like New Enterprise Associates (NEA). Key achievements include the FDA clearance and CE-IVD marking of their comprehensive tumor profiling kit, making it a pioneering solution in the market. PGDx's impact lies in its ability to provide highly accurate genomic data, thereby facilitating more effective and personalized cancer treatments worldwide.
Personal Genome Diagnostics - M & A Snapshot
Personal Genome Diagnostics - Quick Facts
Who are Personal Genome Diagnostics' competitors?
Companies similar to Personal Genome Diagnostics include Personalis, Foundation Medicine, Neodiagnostix and EcoGenome.
When was Personal Genome Diagnostics founded?
Personal Genome Diagnostics was founded in 2010.
Where is Personal Genome Diagnostics' headquarters located?
Personal Genome Diagnostics' headquarters is located in Baltimore, MD, US.
